Xap Therapeutics
Juan-Jose Guijarro-Leach currently serves as the Head of Analytical Development at Xap Therapeutics, a position held since January 2024. Prior to this role, Juan-Jose was the Head of Analytical Development and Principal Scientist in the same field at GammaDelta Therapeutics from September 2020 to December 2023. Juan-Jose's earlier experience includes serving as a Senior Analytical Development Scientist at Cell and Gene Therapy Catapult from January 2014 to September 2020, following a position as an Analytical Development Scientist. The academic background includes a PhD in Regenerative Medicine from Loughborough University, where the doctoral research focused on the characterisation of human embryonic stem cell processing methods. Prior educational achievements include a Master’s degree in Biochemical Engineering from University College London.
This person is not in any teams
This person is not in any offices
Xap Therapeutics
1 followers
Xap Therapeutics is a start-up biotechnology company that is developing an innovative, synthetic biology-driven platform for cell therapeutics.Xap Therapeutics, formed by biotech entrepreneurs, is a producer of a "chassis" cell which functions in cell therapies through genetically engineered constructs. Xap Therapeutics wasestablished in 2017 by James Patterson, M.D., Ph.D in Cambridge, England.